4565 — Nxera Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual cashflow statement for Nxera Pharma Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	534	1,622	433	1,078	-10,680
Depreciation
Non-Cash Items	417	-972	6,711	3,565	1,841
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,001	2,672	-1,327	3,964	1,088
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	3,441	4,672	7,095	9,952	-5,273
Capital Expenditures	-280	-105	-201	-303	-851
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	34	-45	479	1,346	-62,940
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-246	-150	278	1,043	-63,791
Financing Cash Flow Items	-650	-597	-191	-4,681	-27
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-6,964	20,278	11,123	-4,887	48,329
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3,385	24,633	20,079	6,470	-17,492